Sick sinus syndrome and atrial fibrillation in older persons - A view from the sinoatrial nodal myocyte

Journal of Molecular and Cellular Cardiology

Volumn 83, Issue , 2015, Pages 88-100

  Monfredi, O ^a   Boyett, M R ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Arrhythmia; Atrial fibrillation; Calcium handling; Ion channels; Pacemaking; Sinoatrial node

Indexed keywords

ADENOSINE RECEPTOR; ANKYRIN; ANKYRIN B; CALCIUM BINDING PROTEIN; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALCIUM CHANNEL L TYPE; CALSEQUESTRIN 2; GAP JUNCTION PROTEIN; HYPERPOLARIZATION ACTIVATED CYCLIC NUCLEOTIDE GATED CHANNEL; MICRORNA; MYOSIN HEAVY CHAIN ALPHA; RYANODINE RECEPTOR; SODIUM CHANNEL NAV1.5; TRANSIENT RECEPTOR POTENTIAL CHANNEL M7; UNCLASSIFIED DRUG; VOLTAGE GATED CALCIUM CHANNEL; SCN5A PROTEIN, HUMAN;

ARRHYTHMOGENESIS; ARTIFICIAL HEART PACEMAKER; ATRIAL FIBRILLATION; AUTOSOMAL DOMINANT INHERITANCE; BRADYCARDIA; CALCIUM TRANSPORT; GENE; GENE MUTATION; HEART AUTOMATICITY; HEART BLOCK; HEART FAILURE; HEART REPOLARIZATION; HUMAN; NONHUMAN; POPEYE DOMAIN CONTAING GENE; POTASSIUM CURRENT; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SARCOPLASMIC RETICULUM; SICK SINUS SYNDROME; SODIUM CURRENT; AGED; AGING; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; HEART ATRIUM; HEART MUSCLE CELL; ION TRANSPORT; METABOLISM; PATHOLOGY; SINUS NODE;

AGED; AGING; ANIMALS; ATRIAL FIBRILLATION; BRADYCARDIA; CONNEXINS; GENE EXPRESSION REGULATION; HEART ATRIA; HUMANS; HYPERPOLARIZATION-ACTIVATED CYCLIC NUCLEOTIDE-GATED CHANNELS; ION TRANSPORT; MICRORNAS; MYOCYTES, CARDIAC; NAV1.5 VOLTAGE-GATED SODIUM CHANNEL; RECEPTORS, PURINERGIC P1; RENIN-ANGIOTENSIN SYSTEM; SINOATRIAL NODE;

EID: 84937969599     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2015.02.003     Document Type: Review

References (154)

1. Amasyali B., Kilic A., Kilit C. Sinus node dysfunction and atrial fibrillation: which one dominates?. Int J Cardiol 2014, 175:379-380.
2. Rubenstein J.J., Schulman C.L., Yurchak P.M., DeSanctis R.W. Clinical spectrum of the sick sinus syndrome. Circulation 1972, 46:5-13.
3. Hartel G., Talvensaari T. Treatment of sinoatrial syndrome with permanent cardiac pacing in 90 patients. Acta Med Scand 1975, 198:341-347.
4. Jose A.D., Collison D. The normal range and determinants of the intrinsic heart rate in man. Cardiovasc Res 1970, 4:160-167.
5. Short D.S. The syndrome of alternating bradycardia and tachycardia. Br Heart J 1954, 16:208-214.
6. Ferrer M.I. The sick sinus syndrome in atrial disease. JAMA 1968, 206:645-646.
7. Dobrzynski H., Boyett M.R., Anderson R.H. New insights into pacemaker activity: promoting understanding of sick sinus syndrome. Circulation 2007, 115:1921-1932.
8. Lamas G.A., Lee K.L., Sweeney M.O., Silverman R., Leon A., Yee R., et al. Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. N Engl J Med 2002, 346:1854-1862.
9. Connolly S.J., Kerr C.R., Gent M., Roberts R.S., Yusuf S., Gillis A.M., et al. Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. Canadian Trial of Physiologic Pacing Investigators. N Engl J Med 2000, 342:1385-1391.
10. Andersen H.R., Thuesen L., Bagger J.P., Vesterlund T., Thomsen P.E. Prospective randomised trial of atrial versus ventricular pacing in sick-sinus syndrome. Lancet 1994, 344:1523-1528.
11. de Marneffe M., Gregoire J.M., Waterschoot P., Kestemont M.P. The sinus node function: normal and pathological. Eur Heart J 1993, 14:649-654.
12. Adan V., Crown L.A. Diagnosis and treatment of sick sinus syndrome. Am Fam Physician 2003, 67:1725-1732.
13. Yabek S.M., Jarmakani J.M. Sinus node dysfunction in children, adolescents, and young adults. Pediatrics 1978, 61:593-598.
14. Hayes C.J., Gersony W.M. Arrhythmias after the Mustard operation for transposition of the great arteries: a long-term study. J Am Coll Cardiol 1986, 7:133-137.
15. Beder S.D., Gillette P.C., Garson A., Porter C.B., McNamara D.G. Symptomatic sick sinus syndrome in children and adolescents as the only manifestation of cardiac abnormality or associated with unoperated congenital heart disease. Am J Cardiol 1983, 51:1133-1136.
16. Greenwood R.D., Rosenthal A., Sloss L.J., LaCorte M., Nadas A.S. Sick sinus syndrome after surgery for congenital heart disease. Circulation 1975, 52:208-213.
17. Abe K., Machida T., Sumitomo N., Yamamoto H., Ohkubo K., Watanabe I., et al. Sodium channelopathy underlying familial sick sinus syndrome with early onset and predominantly male characteristics. Circ Arrhythm Electrophysiol 2014, 7(3):511-517.
18. Bernstein A.D., Parsonnet V. Survey of cardiac pacing and defibrillation in the United States in 1993. Am J Cardiol 1996, 78:187-196.
19. Jensen P.N., Gronroos N.N., Chen L.Y., Folsom A.R., deFilippi C., Heckbert S.R., et al. Incidence of and risk factors for sick sinus syndrome in the general population. J Am Coll Cardiol 2014, 64:531-538.
20. Semelka M., Gera J., Usman S. Sick sinus syndrome: a review. Am Fam Physician 2013, 87:691-696.
21. Birchfield R.I., Menefee E.E., Bryant G.D. Disease of the sinoatrial node associated with bradycardia, asystole, syncope, and paroxysmal atrial fibrillation. Circulation 1957, 16:20-26.
22. Kaplan B.M., Langendorf R., Lev M., Pick A. Tachycardia-bradycardia syndrome (so-called "sick sinus syndrome"). Pathology, mechanisms and treatment. Am J Cardiol 1973, 31:497-508.
23. Gomes J.A., Kang P.S., Matheson M., Gough W.B., El-Sherif N. Coexistence of sick sinus rhythm and atrial flutter-fibrillation. Circulation 1981, 63:80-86.
24. Shiraishi I., Takamatsu T., Minamikawa T., Onouchi Z., Fujita S. Quantitative histological analysis of the human sinoatrial node during growth and aging. Circulation 1992, 85:2176-2184.
25. Pattanshetty D.J., Bhat P.K., Chamberlain W.A., Lyons M.R. Isolated cardiac involvement in primary amyloidosis: presenting as sick sinus syndrome and heart failure. Tex Heart Inst J 2013, 40:615-618.
26. Ton K., Schulman S., Lima J., Tandri H. Cardiac sarcoidosis presenting as sick sinus syndrome and recurrent ventricular tachycardia. J Am Coll Cardiol 2014, 63. [12_s].
27. Inazumi T., Tajima S., Ando T., Shimada M. A case of CREST syndrome associated with sick sinus syndrome. J Dermatol 1995, 22:801-803.
28. Wang T.L., Chen W.J., Liau C.S., Lee Y.T. Sick sinus syndrome as the early manifestation of cardiac hemochromatosis. J Electrocardiol 1994, 27:91-96.
29. Haq M., Patel A., Guglin M. Cardiac lymphoma: sinus pauses disappear after chemotherapy. Ann Hematol 2014, 93:891-892.
30. Maisch B., Lotze U., Schneider J., Kochsiek K. Antibodies to human sinus node in sick sinus syndrome. Pacing Clin Electrophysiol 1986, 9:1101-1109.
31. Demoulin J.C., Servais J.C., Bury J. A case of diphtheric myocarditis. Anatomoclinical study with histology of the conduction system. Acta Cardiol 1978, 33:143-154.
32. Elizari M.V., Chiale P.A. Cardiac arrhythmias in Chagas' heart disease. J Cardiovasc Electrophysiol 1993, 4:596-608.
33. Bartunek P., Nemec J., Mrazek V., Gorican K., Zapletalova J. Borrelia burgdorferi as a cause of sick sinus syndrome?. Cas Lek Cesk 1996, 135:729-731.
34. Alonso A., Jensen P.N., Lopez F.L., Chen L.Y., Psaty B.M., Folsom A.R., et al. Association of sick sinus syndrome with incident cardiovascular disease and mortality: the Atherosclerosis Risk in Communities Study and Cardiovascular Health Study. PLoS One 2014, 9:e109662.
35. Shaw D.B., Linker N.J., Heaver P.A., Evans R. Chronic sinoatrial disorder (sick sinus syndrome): a possible result of cardiac ischaemia. Br Heart J 1987, 58:598-607.
36. James T.N. Pericarditis and the sinus node. Arch Intern Med 1962, 110:305-311.
37. Okuyan E., Uslu A., Ozan Levent M. Cardiac effects of "mad honey": a case series. Clin Toxicol (Phila) 2010, 48:528-532.
38. Bognolo D.A., Rabow F.I., Vijayanagar R.R., Eckstein P.F. Traumatic sinus node dysfunction. Ann Emerg Med 1982, 11:319-321.
39. Schlesinger Z., Rosenberg T., Stryjer D., Gilboa Y. Exit block in myxedema, treated effectively by thyroid hormone therapy. Pacing Clin Electrophysiol 1980, 3:737-739.
40. Benson D.W., Wang D.W., Dyment M., Knilans T.K., Fish F.A., Strieper M.J., et al. Congenital sick sinus syndrome caused by recessive mutations in the cardiac sodium channel gene (SCN5A). J Clin Invest 2003, 112:1019-1028.
41. Bharati S., Surawicz B., Vidaillet H.J., Lev M. Familial congenital sinus rhythm anomalies: clinical and pathological correlations. Pacing Clin Electrophysiol 1992, 15:1720-1729.
42. Caralis D.G., Varghese P.J. Familial sinoatrial node dysfunction. Increased vagal tone a possible aetiology. Br Heart J 1976, 38:951-956.
43. Makiyama T., Akao M., Tsuji K., Doi T., Ohno S., Takenaka K., et al. High risk for bradyarrhythmic complications in patients with Brugada syndrome caused by SCN5A gene mutations. J Am Coll Cardiol 2005, 46:2100-2106.
44. Milanesi R., Baruscotti M., Gnecchi-Ruscone T., DiFrancesco D. Familial sinus bradycardia associated with a mutation in the cardiac pacemaker channel. N Engl J Med 2006, 354:151-157.
45. Nof E., Luria D., Brass D., Marek D., Lahat H., Reznik-Wolf H., et al. Point mutation in the HCN4 cardiac ion channel pore affecting synthesis, trafficking, and functional expression is associated with familial asymptomatic sinus bradycardia. Circulation 2007, 116:463-470.
46. Schulze-Bahr E., Neu A., Friederich P., Kaupp U.B., Breithardt G., Pongs O., et al. Pacemaker channel dysfunction in a patient with sinus node disease. J Clin Invest 2003, 111:1537-1545.
47. Ueda K., Nakamura K., Hayashi T., Inagaki N., Takahashi M., Arimura T., et al. Functional characterization of a trafficking-defective HCN4 mutation, D553N, associated with cardiac arrhythmia. J Biol Chem 2004, 279:27194-27198.
48. Ewy G.A. Sick sinus syndrome: synopsis. J Am Coll Cardiol 2014, 64:539-540.
49. Alings A.M., Bouman L.N. Electrophysiology of the ageing rabbit and cat sinoatrial node - a comparative study. Eur Heart J 1993, 14:1278-1288.
50. Herrmann S., Fabritz L., Layh B., Kirchhof P., Ludwig A. Insights into sick sinus syndrome from an inducible mouse model. Cardiovasc Res 2011, 90:38-48.
51. Morris G.M., Monfredi O., Boyett M.R. Not so fast! Sick sinus syndrome is a complex and incompletely understood disease that might prove hard to model in animals. Cardiovasc Res 2011, 92:178. [author reply 9].
52. Hao X., Zhang Y., Zhang X., Nirmalan M., Davies L., Konstantinou D., et al. TGF-β1-mediated fibrosis and ion channel remodeling are key mechanisms in producing the sinus node dysfunction associated with SCN5A deficiency and aging. Circ Arrhythm Electrophysiol 2011, 4:397-406.
53. 2+ clock genes underlying sino-atrial node pacemaking. Exp Physiol 2011, 96:1163-1178.
54. Monfredi O., Maltsev V.A., Lakatta E.G. Modern concepts concerning the origin of the heartbeat. Physiology (Bethesda) 2013, 28:74-92.
55. Boyett M.R., Honjo H., Kodama I. The sinoatrial node, a heterogeneous pacemaker structure. Cardiovasc Res 2000, 47:658-687.
56. Na, and cell death in cardiac pacemaking and driving. Am J Physiol Heart Circ Physiol 2007, 292:H165-H174.
57. Lei M., Goddard C., Liu J., Leoni A.L., Royer A., Fung S.S., et al. Sinus node dysfunction following targeted disruption of the murine cardiac sodium channel gene Scn5a. J Physiol 2005, 567:387-400.
58. Liu M., Yang K.C., Dudley S.C. Cardiac sodium channel mutations: why so many phenotypes?. Nat Rev Cardiol 2014, 11(10):607-615.
59. Arnolds D.E., Liu F., Fahrenbach J.P., Kim G.H., Schillinger K.J., Smemo S., et al. TBX5 drives Scn5a expression to regulate cardiac conduction system function. J Clin Invest 2012, 122:2509-2518.
60. Schroder E.A., Lefta M., Zhang X., Bartos D.C., Feng H.Z., Zhao Y., et al. The cardiomyocyte molecular clock, regulation of Scn5a, and arrhythmia susceptibility. Am J Physiol Cell Physiol 2013, 304:C954-C965.
61. v1.5 and β3 subunit. J Mol Cell Cardiol 2014, 74:297-306.
62. Kaur K., Zarzoso M., Ponce-Balbuena D., Guerrero-Serna G., Hou L., Musa H., et al. TGF-β1, released by myofibroblasts, differentially regulates transcription and function of sodium and potassium channels in adult rat ventricular myocytes. PLoS One 2013, 8:e55391.
63. v1.5 expression through Foxo1. PLoS One 2012, 7:e32738.
64. Steggerda S.M., Paschal B.M. Identification of a conserved loop in Mog1 that releases GTP from Ran. Traffic 2001, 2:804-811.
65. v1.5 mutations in Brugada syndrome and sick sinus syndrome. Circ Arrhythm Electrophysiol 2013, 6:392-401.
66. Wu L., Yong S.L., Fan C., Ni Y., Yoo S., Zhang T., et al. Identification of a new co-factor, MOG1, required for the full function of cardiac sodium channel Nav 1.5. J Biol Chem 2008, 283:6968-6978.
67. + channels in the developing mouse heart. J Physiol 2005, 564:683-696.
68. Lei M., Jones S.A., Liu J., Lancaster M.K., Fung S.S., Dobrzynski H., et al. Requirement of neuronal- and cardiac-type sodium channels for murine sinoatrial node pacemaking. J Physiol 2004, 559:835-848.
69. v1.6 disrupts action potential propagation and excitation-contraction coupling in the mouse heart. FASEB J 2012, 26:63-72.
70. v1.8 channels in intracardiac neurons: the link between SCN10A and cardiac electrophysiology. Circ Res 2012, 111:333-343.
71. Chambers J.C., Zhao J., Terracciano C.M., Bezzina C.R., Zhang W., Kaba R., et al. Genetic variation in SCN10A influences cardiac conduction. Nat Genet 2010, 42:149-152.
72. Makiyama T., Akao M., Shizuta S., Doi T., Nishiyama K., Oka Y., et al. A novel SCN5A gain-of-function mutation M1875T associated with familial atrial fibrillation. J Am Coll Cardiol 2008, 52:1326-1334.
73. Bezzina C.R., Rook M.B., Groenewegen W.A., Herfst L.J., van der Wal A.C., Lam J., et al. Compound heterozygosity for mutations (W156X and R225W) in SCN5A associated with severe cardiac conduction disturbances and degenerative changes in the conduction system. Circ Res 2003, 92:159-168.
74. Adsit G.S., Vaidyanathan R., Galler C.M., Kyle J.W., Makielski J.C. Channelopathies from mutations in the cardiac sodium channel protein complex. J Mol Cell Cardiol 2013, 61:34-43.
75. Amin A.S., Asghari-Roodsari A., Tan H.L. Cardiac sodium channelopathies. Pflugers Arch 2010, 460:223-237.
76. Remme C.A. Cardiac sodium channelopathy associated with SCN5A mutations: electrophysiological, molecular and genetic aspects. J Physiol 2013, 591:4099-4116.
77. Ruan Y., Liu N., Priori S.G. Sodium channel mutations and arrhythmias. Nat Rev Cardiol 2009, 6:337-348.
78. Zimmer T., Surber R. SCN5A channelopathies - an update on mutations and mechanisms. Prog Biophys Mol Biol 2008, 98:120-136.
79. Lei M., Zhang H., Grace A.A., Huang C.L. SCN5A and sinoatrial node pacemaker function. Cardiovasc Res 2007, 74:356-365.
80. Veldkamp M.W., Wilders R., Baartscheer A., Zegers J.G., Bezzina C.R., Wilde A.A. Contribution of sodium channel mutations to bradycardia and sinus node dysfunction in LQT3 families. Circ Res 2003, 92:976-983.
81. Wang Q., Li Z., Shen J., Keating M.T. Genomic organization of the human SCN5A gene encoding the cardiac sodium channel. Genomics 1996, 34:9-16.
82. Papadatos G.A., Wallerstein P.M., Head C.E., Ratcliff R., Brady P.A., Benndorf K., et al. Slowed conduction and ventricular tachycardia after targeted disruption of the cardiac sodium channel gene Scn5a. Proc Natl Acad Sci U S A 2002, 99:6210-6215.
83. 2+ clocks and surface membrane voltage clocks controls the timekeeping mechanism of the heart's pacemaker. Circ Res 2010, 106:659-673.
84. Wahl-Schott C., Fenske S., Biel M. HCN channels: new roles in sinoatrial node function. Curr Opin Pharmacol 2014, 15:83-90.
85. Alig J., Marger L., Mesirca P., Ehmke H., Mangoni M.E., Isbrandt D. Control of heart rate by cAMP sensitivity of HCN channels. Proc Natl Acad Sci U S A 2009, 106:12189-12194.
86. Stieber J., Herrmann S., Feil S., Loster J., Feil R., Biel M., et al. The hyperpolarization-activated channel HCN4 is required for the generation of pacemaker action potentials in the embryonic heart. Proc Natl Acad Sci U S A 2003, 100:15235-15240.
87. Baruscotti M., Bucchi A., Viscomi C., Mandelli G., Consalez G., Gnecchi-Rusconi T., et al. Deep bradycardia and heart block caused by inducible cardiac-specific knockout of the pacemaker channel gene Hcn4. Proc Natl Acad Sci U S A 2011, 108:1705-1710.
88. Harzheim D., Pfeiffer K.H., Fabritz L., Kremmer E., Buch T., Waisman A., et al. Cardiac pacemaker function of HCN4 channels in mice is confined to embryonic development and requires cyclic AMP. EMBO J 2008, 27:692-703.
89. Herrmann S., Stieber J., Stockl G., Hofmann F., Ludwig A. HCN4 provides a 'depolarization reserve' and is not required for heart rate acceleration in mice. EMBO J 2007, 26:4423-4432.
90. Hoesl E., Stieber J., Herrmann S., Feil S., Tybl E., Hofmann F., et al. Tamoxifen-inducible gene deletion in the cardiac conduction system. J Mol Cell Cardiol 2008, 45:62-69.
91. Herrmann S., Layh B., Ludwig A. Novel insights into the distribution of cardiac HCN channels: an expression study in the mouse heart. J Mol Cell Cardiol 2011, 51:997-1006.
92. Marionneau C., Couette B., Liu J., Li H., Mangoni M.E., Nargeot J., et al. Specific pattern of ionic channel gene expression associated with pacemaker activity in the mouse heart. J Physiol 2005, 562:223-234.
93. Altomare C., Terragni B., Brioschi C., Milanesi R., Pagliuca C., Viscomi C., et al. Heteromeric HCN1-HCN4 channels: a comparison with native pacemaker channels from the rabbit sinoatrial node. J Physiol 2003, 549:347-359.
94. Shi W., Wymore R., Yu H., Wu J., Wymore R.T., Pan Z., et al. Distribution and prevalence of hyperpolarization-activated cation channel (HCN) mRNA expression in cardiac tissues. Circ Res 1999, 85:e1-e6.
95. f. J Biol Chem 2001, 276:29233-29241.
96. Sah R., Mesirca P., Van den Boogert M., Rosen J., Mably J., Mangoni M.E., et al. Ion channel-kinase TRPM7 is required for maintaining cardiac automaticity. Proc Natl Acad Sci U S A 2013, 110:E3037-E3046.
97. Fenske S., Krause S.C., Hassan S.I., Becirovic E., Auer F., Bernard R., et al. Sick sinus syndrome in HCN1-deficient mice. Circulation 2013, 128:2585-2594.
98. Huang X., Yang P., Du Y., Zhang J., Ma A. Age-related down-regulation of HCN channels in rat sinoatrial node. Basic Res Cardiol 2007, 102:429-435.
99. Wainger B.J., DeGennaro M., Santoro B., Siegelbaum S.A., Tibbs G.R. Molecular mechanism of cAMP modulation of HCN pacemaker channels. Nature 2001, 411:805-810.
100. Ludwig A., Budde T., Stieber J., Moosmang S., Wahl C., Holthoff K., et al. Absence epilepsy and sinus dysrhythmia in mice lacking the pacemaker channel HCN2. EMBO J 2003, 22:216-224.
101. Zicha S., Fernandez-Velasco M., Lonardo G., L'Heureux N., Nattel S. Sinus node dysfunction and hyperpolarization-activated (HCN) channel subunit remodeling in a canine heart failure model. Cardiovasc Res 2005, 66:472-481.
102. f. Int J Cardiol 2009, 132:318-336.
103. Mesirca P., Alig J., Torrente A.G., Muller J.C., Marger L., Rollin A., et al. Cardiac arrhythmia induced by genetic silencing of 'funny' (f) channels is rescued by GIRK4 inactivation. Nat Commun 2014, 5:4664.
104. Fenske S., Mader R., Scharr A., Paparizos C., Cao-Ehlker X., Michalakis S., et al. HCN3 contributes to the ventricular action potential waveform in the murine heart. Circ Res 2011, 109:1015-1023.
105. 2+ current to electrical activity in sinoatrial nodal myocytes of rabbits. Am J Physiol 1999, 276:H1064-H1077.
106. Hagiwara N., Irisawa H., Kameyama M. Contribution of two types of calcium currents to the pacemaker potentials of rabbit sino-atrial node cells. J Physiol 1988, 395:233-253.
107. 2+ channels in cardiac pacemaker activity. Proc Natl Acad Sci U S A 2003, 100:5543-5548.
108. Jones S.A., Boyett M.R., Lancaster M.K. Declining into failure: the age-dependent loss of the L-type calcium channel within the sinoatrial node. Circulation 2007, 115:1183-1190.
109. 2+ channels. Cell 2000, 102:89-97.
110. v1.3 (CACNA1D) function in a human channelopathy with bradycardia and congenital deafness. Nat Neurosci 2011, 14:77-84.
111. Karnabi E., Boutjdir M. Role of calcium channels in congenital heart block. Scand J Immunol 2010, 72:226-234.
112. Hu K., Qu Y., Yue Y., Boutjdir M. Functional basis of sinus bradycardia in congenital heart block. Circ Res 2004, 94:e32-e38.
113. v1.3) L-type calcium channel in autoimmune-associated sinus bradycardia. Circulation 2005, 111:3034-3041.
114. Joung B., Lin S.F., Chen Z., Antoun P.S., Maruyama M., Han S., et al. Mechanisms of sinoatrial node dysfunction in a canine model of pacing-induced atrial fibrillation. Heart Rhythm 2010, 7:88-95.
115. Yeh Y.H., Burstein B., Qi X.Y., Sakabe M., Chartier D., Comtois P., et al. Funny current downregulation and sinus node dysfunction associated with atrial tachyarrhythmia: a molecular basis for tachycardia-bradycardia syndrome. Circulation 2009, 119:1576-1585.
116. 2+ signaling. Am J Physiol Heart Circ Physiol 2014, 306:H1385-H1397.
117. Wu Y., Gao Z., Chen B., Koval O.M., Singh M.V., Guan X., et al. Calmodulin kinase II is required for fight or flight sinoatrial node physiology. Proc Natl Acad Sci U S A 2009, 106:5972-5977.
118. Erickson J.R., Joiner M.L., Guan X., Kutschke W., Yang J., Oddis C.V., et al. A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation. Cell 2008, 133:462-474.
119. Swaminathan P.D., Purohit A., Soni S., Voigt N., Singh M.V., Glukhov A.V., et al. Oxidized CaMKII causes cardiac sinus node dysfunction in mice. J Clin Invest 2011, 121:3277-3288.
120. Sumitomo N., Sakurada H., Taniguchi K., Matsumura M., Abe O., Miyashita M., et al. Association of atrial arrhythmia and sinus node dysfunction in patients with catecholaminergic polymorphic ventricular tachycardia. Circ J 2007, 71:1606-1609.
121. 2+ release, and catecholaminergic polymorphic ventricular tachycardia. J Clin Invest 2006, 116:2510-2520.
122. 2+ uptake leads to cardiac hypertrophy, contractile dysfunction and early mortality in mice deficient in CASQ2. Cardiovasc Res 2013, 98:297-306.
123. 2+ release and decreased sinoatrial node activity in a mouse model of catecholaminergic polymorphic ventricular tachycardia. Circulation 2012, 126:392-401.
124. Glukhov A.V., Kalyanasundaram A., Lou Q., Hage L.T., Hansen B.J., Belevych A.E., et al. Calsequestrin 2 deletion causes sinoatrial node dysfunction and atrial arrhythmias associated with altered sarcoplasmic reticulum calcium cycling and degenerative fibrosis within the mouse atrial pacemaker complex. Eur Heart J 2013, (Epub ahead of print). 10.1093/eurheartj/eht452.
125. Jones S.A., Lancaster M.K., Boyett M.R. Ageing-related changes of connexins and conduction within the sinoatrial node. J Physiol 2004, 560:429-437.
126. Luu M., Stevenson W.G., Stevenson L.W., Baron K., Walden J. Diverse mechanisms of unexpected cardiac arrest in advanced heart failure. Circulation 1989, 80:1675-1680.
127. Stevenson W.G., Stevenson L.W., Middlekauff H.R., Saxon L.A. Sudden death prevention in patients with advanced ventricular dysfunction. Circulation 1993, 88:2953-2961.
128. Funaya H., Kitakaze M., Node K., Minamino T., Komamura K., Hori M. Plasma adenosine levels increase in patients with chronic heart failure. Circulation 1997, 95:1363-1365.
129. Lou Q., Hansen B.J., Fedorenko O., Csepe T.A., Kalyanasundaram A., Li N., et al. Upregulation of adenosine A1 receptors facilitates sinoatrial node dysfunction in chronic canine heart failure by exacerbating nodal conduction abnormalities revealed by novel dual-sided intramural optical mapping. Circulation 2014, 130:315-324.
130. Saito K., Gutkind J.S., Saavedra J.M. Angiotensin II binding sites in the conduction system of rat hearts. Am J Physiol 1987, 253:H1618-H1622.
131. Vongvatcharanon U., Vongvatcharanon S., Radenahmad N., Kirirat P., Intasaro P., Sobhon P., et al. Angiotensin II may mediate apoptosis via AT1-receptors in the rat cardiac conduction system. J Renin Angiotensin Aldosterone Syst 2004, 5:135-140.
132. Sadoshima J., Izumo S. Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype. Circ Res 1993, 73:413-423.
133. Hein L., Stevens M.E., Barsh G.S., Pratt R.E., Kobilka B.K., Dzau V.J. Overexpression of angiotensin AT1 receptor transgene in the mouse myocardium produces a lethal phenotype associated with myocyte hyperplasia and heart block. Proc Natl Acad Sci U S A 1997, 94:6391-6396.
134. Chen J.Y., Liou Y.M., Wu H.D., Lin K.H., Chang K.C. Promoter polymorphism G-6A, which modulates angiotensinogen gene expression, is associated with non-familial sick sinus syndrome. PLoS One 2012, 7:e29951.
135. Schindler R.F., Poon K.L., Simrick S., Brand T. The Popeye domain containing genes: essential elements in heart rate control. Cardiovasc Diagn Ther 2012, 2:308-319.
136. Froese A., Breher S.S., Waldeyer C., Schindler R.F., Nikolaev V.O., Rinne S., et al. Popeye domain containing proteins are essential for stress-mediated modulation of cardiac pacemaking in mice. J Clin Invest 2012, 122:1119-1130.
137. Luo X., Zhang H., Xiao J., Wang Z. Regulation of human cardiac ion channel genes by microRNAs: theoretical perspective and pathophysiological implications. Cell Physiol Biochem 2010, 25:571-586.
138. van Rooij E., Sutherland L.B., Liu N., Williams A.H., McAnally J., Gerard R.D., et al. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci U S A 2006, 103:18255-18260.
139. K1 up-regulation in human atrial fibrillation. Heart Rhythm 2009, 6:1802-1809.
140. Wang J., Bai Y., Li N., Ye W., Zhang M., Greene S.B., et al. Pitx2-microRNA pathway that delimits sinoatrial node development and inhibits predisposition to atrial fibrillation. Proc Natl Acad Sci U S A 2014, 111:9181-9186.
141. Bennett V., Healy J. Organizing the fluid membrane bilayer: diseases linked to spectrin and ankyrin. Trends Mol Med 2008, 14:28-36.
142. Le Scouarnec S., Bhasin N., Vieyres C., Hund T.J., Cunha S.R., Koval O., et al. Dysfunction in ankyrin-B-dependent ion channel and transporter targeting causes human sinus node disease. Proc Natl Acad Sci U S A 2008, 105:15617-15622.
143. Mohler P.J., Splawski I., Napolitano C., Bottelli G., Sharpe L., Timothy K., et al. A cardiac arrhythmia syndrome caused by loss of ankyrin-B function. Proc Natl Acad Sci U S A 2004, 101:9137-9142.
144. Mohler P.J., Schott J.J., Gramolini A.O., Dilly K.W., Guatimosim S., duBell W.H., et al. Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death. Nature 2003, 421:634-639.
145. Mohler P.J., Le Scouarnec S., Denjoy I., Lowe J.S., Guicheney P., Caron L., et al. Defining the cellular phenotype of "ankyrin-B syndrome" variants: human ANK2 variants associated with clinical phenotypes display a spectrum of activities in cardiomyocytes. Circulation 2007, 115:432-441.
146. Mohler P.J., Davis J.Q., Bennett V. Ankyrin-B coordinates the Na/K ATPase, Na/Ca exchanger, and InsP3 receptor in a cardiac T-tubule/SR microdomain. PLoS Biol 2005, 3:e423.
147. Holm H., Gudbjartsson D.F., Sulem P., Masson G., Helgadottir H.T., Zanon C., et al. A rare variant in MYH6 is associated with high risk of sick sinus syndrome. Nat Genet 2011, 43:316-320.
148. Holm H., Gudbjartsson D.F., Arnar D.O., Thorleifsson G., Thorgeirsson G., Stefansdottir H., et al. Several common variants modulate heart rate, PR interval and QRS duration. Nat Genet 2010, 42:117-122.
149. Alings A.M., Abbas R.F., Bouman L.N. Age-related changes in structure and relative collagen content of the human and feline sinoatrial node. A comparative study. Eur Heart J 1995, 16:1655-1667.
150. Chen Y.C., Lu Y.Y., Cheng C.C., Lin Y.K., Chen S.A., Chen Y.J. Sinoatrial node electrical activity modulates pulmonary vein arrhythmogenesis. Int J Cardiol 2014, 173:447-452.
151. Kose S., Amasyali B., Kursaklioglu H., Kilic A., Isik E. Permanent junctional reciprocating tachycardia: an unusual presentation. Int J Clin Pract 2009, 63:518-521.
152. Sanders P., Morton J.B., Kistler P.M., Spence S.J., Davidson N.C., Hussin A., et al. Electrophysiological and electroanatomic characterization of the atria in sinus node disease: evidence of diffuse atrial remodeling. Circulation 2004, 109:1514-1522.
153. Sanders P., Kistler P.M., Morton J.B., Spence S.J., Kalman J.M. Remodeling of sinus node function in patients with congestive heart failure: reduction in sinus node reserve. Circulation 2004, 110:897-903.
154. Sairaku A., Nakano Y., Oda N., Makita Y., Kajihara K., Tokuyama T., et al. Prediction of sinus node dysfunction in patients with persistent atrial flutter using the flutter cycle length. Europace 2012, 14:380-387.